⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1815629 | 0.84 | — | — | |
| SCHEMBL5521713 | 0.76 | — | — | |
| SCHEMBL2334647 | 0.75 | — | — | |
| SCHEMBL2366613 | 0.74 | — | — | |
| SCHEMBL856758 | 0.73 | — | — | |
| SCHEMBL20660050 | 0.73 | — | — | |
| SCHEMBL4390587 | 0.70 | — | — | |
| SCHEMBL5196121 | 0.69 | — | — | |
| SCHEMBL28603125 | 0.68 | — | — | |
| SCHEMBL9818515 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105669566-A | Preparation method of pharmaceutical intermediate N-arylquinazolinyl-amine compounds | 华东师范大学 | 2016-06-15 | — | — | CN | claimed |
| CN-105419785-A | Subject and object compounded multi-photon polarization laser material based on metal-organic framework and preparation method of subject and object compounded multi-photon polarization laser material | UNIV ZHEJIANG | 2016-03-23 | — | — | CN | claimed |
| CN-103880683-A | Chemical synthesis method of 3-bromo-2-nitrobenzaldehyde | UNIV NANTONG | 2014-06-25 | — | — | CN | claimed |
| CN-110312711-A | Heterocyclic compound and its application method as RAS inhibitor | 亚瑞克西斯制药公司 | 2019-10-08 | — | — | CN | disclosed |
| CN-110117273-A | 2H- indazole derivative and its medical application as cell cycle protein dependent kinase (CDK) inhibitor | 贝达医药公司 | 2019-08-13 | — | — | CN | disclosed |
| CN-105814040-B | The condensed 1,4- dihydro two of inhibitor as thermal excited transcryption factor 1 dislikes ene derivative | 癌症研究科技有限公司 | 2019-07-30 | — | — | CN | disclosed |
| CN-106687454-B | 2H-indazole derivatives as Cyclin Dependent Kinase (CDK) inhibitors and their medical use | 贝达医药公司 | 2019-06-21 | — | — | CN | disclosed |
| CN-109476646-A | Dicyclic compound as pest control agent | 拜耳作物科学股份公司 | 2019-03-15 | — | — | CN | disclosed |
| CN-109096192-A | The benzo-aza * of 8- substitutions is as class TOLL receptor modulators | 阿雷生物药品公司 | 2018-12-28 | — | — | CN | disclosed |
| CN-109096193-A | The benzo-aza * of 8- substitutions is as class TOLL receptor modulators | 阿雷生物药品公司 | 2018-12-28 | — | — | CN | disclosed |
| CN-106397318-B | A kind of 10- nitrogen (miscellaneous) anthracene derivant and its preparation method and application | 长春海谱润斯科技有限公司 | 2018-12-25 | — | — | CN | disclosed |
| EP-2044083-A1 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. (US) | 2009-04-08 | — | — | EP | disclosed |
| US-20080051384-A1 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. | 2008-02-28 | — | — | US | disclosed |
| WO-2008008907-A2 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| WO-2008008912-A1 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| CN-101103026-A | Bicyclic heteroaryl derivatives for treating viruses | GENELABS INC (US) | 2008-01-09 | — | — | CN | disclosed |
| EP-1844042-A1 | INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS | GENELABS TECHNOLOGIES, INC. (US) | 2007-10-17 | — | — | EP | disclosed |
| WO-2007109334-A2 | SIP RECEPTOR MODULATING COMPOUNDS AND USE THEREOF | EPIX DELAWARE, INC. (US) | 2007-09-27 | — | — | WO | disclosed |
| US-20060211698-A1 | Bicyclic heteroaryl derivatives for treating viruses | GENELABS, INC. | 2006-09-21 | — | — | US | disclosed |
| WO-2006076529-A1 | INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS | GENELABS TECHNOLOGIES, INC. (US) | 2006-07-20 | — | — | WO | disclosed |